Suggestions
Abul Basar
Vice President, Head of Global Value & Access at Gilead Sciences
Abul Basar is a seasoned professional with a solid academic foundation in Pharmacy from King's College London. With a wealth of experience in the pharmaceutical industry, Abul has held key leadership positions in various renowned organizations. Currently serving as the Vice President and Head of Global Value & Access at Gilead Sciences, he is instrumental in shaping strategies related to market access and value propositions on a global scale. Prior to his role at Gilead Sciences, Abul held significant roles at Novartis Oncology, including Vice President of Global Value and Access Franchise, Global Oncology Access Disease Lead, and Global Patient Access Franchise Head. He also contributed his expertise as the Global Market Access Director at Novartis. Before his tenure at Novartis, Abul enriched his professional portfolio at GlaxoSmithKline, where he served as the Senior Director of Integrated Access Strategy and Director of Strategic Economic Planning. His early career at Roche Pharmaceuticals saw him excel in the role of Head of Strategic Funding and Capacity.
